JPS4934674B1 - - Google Patents

Info

Publication number
JPS4934674B1
JPS4934674B1 JP45052488A JP5248870A JPS4934674B1 JP S4934674 B1 JPS4934674 B1 JP S4934674B1 JP 45052488 A JP45052488 A JP 45052488A JP 5248870 A JP5248870 A JP 5248870A JP S4934674 B1 JPS4934674 B1 JP S4934674B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP45052488A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4934674B1 publication Critical patent/JPS4934674B1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
JP45052488A 1969-06-25 1970-06-18 Pending JPS4934674B1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83660569A 1969-06-25 1969-06-25
US3029870A 1970-04-20 1970-04-20

Publications (1)

Publication Number Publication Date
JPS4934674B1 true JPS4934674B1 (ja) 1974-09-17

Family

ID=26705877

Family Applications (1)

Application Number Title Priority Date Filing Date
JP45052488A Pending JPS4934674B1 (ja) 1969-06-25 1970-06-18

Country Status (7)

Country Link
US (2) US3700773A (ja)
JP (1) JPS4934674B1 (ja)
CH (1) CH533604A (ja)
DE (1) DE2031233A1 (ja)
FR (1) FR2053025B1 (ja)
GB (1) GB1277153A (ja)
NL (1) NL7008631A (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5917276A (ja) * 1982-07-20 1984-01-28 Hitachi Ltd 半導体装置

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399632A (en) * 1972-07-13 1975-07-02 Leo Pharm Prod Ltd Sulphamoyl-benzoic acids
GB1458029A (en) * 1972-12-26 1976-12-08 Pfizer Sulphamylbenzoic acids and preparation thereof
US4172210A (en) * 1977-06-13 1979-10-23 American Cyanamid Company S-Phenenyltris(sulfonylimino)tri-anionic substituted benzene carboxylic acids
US4143151A (en) * 1978-07-03 1979-03-06 The Dow Chemical Company Method for treating hyperglycemia in mammals using arylamino benzoic acids
US4207330A (en) * 1978-07-03 1980-06-10 The Dow Chemical Company Method for treating hyperglycemia in mammals using arylamino benzoic acids
AU539648B2 (en) * 1981-11-24 1984-10-11 Medea Researches S.R.L. 2,4-dioxa-benzocyclohexanone-1 derivatives
JPH0660160B2 (ja) * 1985-12-13 1994-08-10 テルモ株式会社 アミド誘導体およびこれを含有する抗アレルギ−剤
DE3713757A1 (de) * 1987-04-24 1988-11-10 Hoechst Ag Benzolsulfonamidderivate und verfahren zu ihrer herstellung
EP0462179A4 (en) * 1989-02-27 1992-03-18 The Du Pont Merck Pharmaceutical Company Novel sulfonamides as radiosensitizers
US5470882A (en) * 1994-06-02 1995-11-28 Smithkline Beecham Corp. Anti-inflammatory compounds
US5545669A (en) * 1994-06-02 1996-08-13 Adams; Jerry L. Anti-inflammatory compounds
US6653331B2 (en) * 1996-07-03 2003-11-25 Pharmacia & Upjohn Company Targeted drug delivery using sulfonamide derivatives
AU759255B2 (en) 1998-01-29 2003-04-10 Amgen, Inc. PPAR-gamma modulators
US6583157B2 (en) 1998-01-29 2003-06-24 Tularik Inc. Quinolinyl and benzothiazolyl modulators
US7041691B1 (en) * 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
WO2001082916A2 (en) * 2000-05-03 2001-11-08 Tularik Inc. Combination therapeutic compositions and methods of use
US20030171399A1 (en) * 2000-06-28 2003-09-11 Tularik Inc. Quinolinyl and benzothiazolyl modulators
AU9233101A (en) * 2000-10-04 2002-04-15 Kissei Pharmaceutical 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
US7223761B2 (en) * 2003-10-03 2007-05-29 Amgen Inc. Salts and polymorphs of a potent antidiabetic compound
US6806291B1 (en) * 2003-10-09 2004-10-19 The Foundation For The Lsu Health Sciences Center Analgesic compounds, their synthesis and pharmaceutical compositions containing them
AU2005221140A1 (en) * 2004-03-08 2005-09-22 Amgen Inc. Therapeutic modulation of PPAR (gamma) activity
WO2017153952A1 (en) * 2016-03-10 2017-09-14 Glaxosmithkline Intellectual Property Development Limited 5-sulfamoyl-2-hydroxybenzamide derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2103522A (en) * 1936-12-03 1937-12-28 Farastan Company Therapeutic composition
US2852557A (en) * 1954-04-09 1958-09-16 Schenley Ind Inc 4-sulfonyl derivatives of salicylic acid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5917276A (ja) * 1982-07-20 1984-01-28 Hitachi Ltd 半導体装置

Also Published As

Publication number Publication date
DE2031233A1 (de) 1971-01-07
GB1277153A (en) 1972-06-07
FR2053025B1 (ja) 1973-12-21
CH533604A (de) 1973-02-15
US3674843A (en) 1972-07-04
FR2053025A1 (ja) 1971-04-16
NL7008631A (ja) 1970-12-29
US3700773A (en) 1972-10-24

Similar Documents

Publication Publication Date Title
FR2053025B1 (ja)
AU465452B2 (ja)
AU450150B2 (ja)
AU442375B2 (ja)
AU470301B1 (ja)
AU5113869A (ja)
AU442554B2 (ja)
AU442285B2 (ja)
AU470661B1 (ja)
AU442538B2 (ja)
AU442535B2 (ja)
AU442463B2 (ja)
AU442380B2 (ja)
AU410358B2 (ja)
AU442357B2 (ja)
AU442322B2 (ja)
AU5109569A (ja)
AU4949169A (ja)
AU5077469A (ja)
BE735830A (ja)
AU4815038A (ja)
BE753456A (ja)
BE727494A (ja)
BE733259A (ja)
AU448562A (ja)